Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A Short-Order Oncology Start-Up: Non-Profit Tackles Drug Shortages

This article was originally published in RPM Report

Executive Summary

Drug shortages are a big problem in cancer, where many generic sterile injectables are both life-saving and irreplaceable. Some oncologists have decided to take control and form a manufacturer of their own.

You may also be interested in...



Who Will Solve The Shortage Problem? Hospital Non-Profit Is Latest Idea

Non-profit probably won’t ever be significant threat to industry – but frustration with chronic shortages could prompt policy changes that are.

Early Notification Legislation: What The Bills Say

Both houses have introduced legislation to require manufacturers to notify FDA in advance of planned interruptions or as soon as possible when facing a shortage. Here’s a look at the details.

New EU Filings

Omaveloxolone, Reata Pharmaceuticals’s orphan drug for treating patients with Friedreich’s ataxia, is among the latest drugs that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel